Zentalis Pharmaceuticals Ratios (2021-2026) | ZNTL

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) 25.11%-177.47%
EBIT Margin (Quarter) -61.06%-185.55%
EBITDA Margin (Quarter) -61.06%-185.55%
Operating Margin (Quarter) -61.06%-185.55%
Net Margin (Quarter) 24.75%-176.71%
FCF Margin (Quarter) -128.24%-147.78%
Efficiency
Assets Average (Quarter) 430.09M486.77M548.52M534.25M514.33M555.39M603.58M568.70M554.58M524.58M471.17M440.50M407.18M367.86M339.48M308.11M271.02M
Equity Average (Quarter) 340.07M394.24M450.78M431.38M409.84M454.47M502.59M459.59M448.03M420.68M368.46M345.76M316.28M284.94M263.68M234.54M199.44M
Invested Capital (Quarter) 364.48M315.67M472.82M428.74M434.02M385.67M523.28M481.90M437.28M458.77M382.58M354.33M337.19M295.38M274.50M252.87M216.20M182.68M
Asset Utilization Ratio (Quarter) 0.070.080.090.150.070.070.08
Leverage & Solvency
Equity Ratio (Quarter) 0.800.780.830.810.800.790.840.820.790.820.780.790.780.770.780.770.750.72
Valuation
Enterprise Value (Quarter) -59.43M-30.45M-54.81M-42.32M-42.85M-36.10M-266.42M-110.62M-482.81M-37.62M-36.98M-41.32M-351.91M-320.30M-286.64M-41.48M-245.89M-211.76M
Return Ratios
Return on Sales (Quarter) 0.00%-0.05%-0.04%-0.02%-0.08%-0.06%-0.06%
Return on Capital Employed (Quarter) -47.59%-51.17%-54.57%-52.02%-59.98%-51.89%-48.17%-50.27%-49.31%-59.27%-55.64%-54.67%-56.27%-61.51%
Return on Invested Capital (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%